GSK-J4
-
- Applikation
- Inhibition (Inh)
- Verwendungszweck
- JMJ H3K27 Demethylase inhibitor (cell permeable)
- Produktmerkmale
- Histone demethylase JMJD3/UTX inhibitor. Inhibits demethylation of histone H3K27. Reduces LPS-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 μM for the inhibition of TNFα release). Cell permeable, ethyl ester of GSK J1. Rescues newborn pups from embryonic lethality in BRAF knockin mice which recapitulate major features of RASopathies.
- Reinheit
- >98 %
- Chemical Name
- N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine ethyl ester
- Formel
- C24H27N5O2
- Permeabilität
- Cell-permeable
- Löslichkeit
- Soluble in DMSO (up to 40 mg/ml) or in Ethanol (up to 40 mg/ml).
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Wax
- Lagerung
- -20 °C
-
- Hintergrund
- Epigenetics,Posttranslational modification,Protein demethylase,Immunology,Inflammation,Cytokine,Chromatin
- Molekulargewicht
- 417.48
- CAS-Nummer
- 1373423-53-0
-